What is VYNE's dilution risk score?

VYNE has a latest available DilutionScore record of 56/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for VYNE, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for VYNE?

DilutionWatch tracks 25 SEC filing types for VYNE including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect VYNE shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For VYNE, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for VYNE tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for VYNE. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

VYNE Dilution Risk Score: 56/100 (HIGH)

Score Breakdown

📋 Offering Ability

60

💰 Cash Runway

65

📊 Float Risk

7

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

⛈️

Warning

High probability of dilution event

model est. 37%

🔄 Reverse Split model est. 65%

• 50-day avg $0.64 below $1 exchange minimum

• 10 months cash with weak price

💰 Capital Raise model 15%

• Under 12 months cash (10mo)

🔔 Track VYNE — Get forecast alerts →

Market Data

Market Cap$22.74M

Shares Outstanding33.35M

Float32.55M

Cash$23.22M

DebtN/A

Short InterestN/A

Institutional Holdings

QoQ: ↑ 74.6% shares (2026Q1 vs prior)

46 institutional holders · 14.73M shares

#1 Anson Funds Management LP 2.49M shares

#2 Nantahala Capital Management, LLC 2.00M shares

#3 Lynx1 Capital Management LP 1.63M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest184.0K

Days to Cover1.0

% of Float0.6%

FINRA data as of Jul 15, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-30

xbrl XBRL CONVERTIBLE 2018-12-31

4 INSIDER TRANSACTION 2026-04-02

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual VYNE Dilution Snapshot

VYNE Therapeutics Inc. (VYNE) has a DilutionScore of 56/100, rated High dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for VYNE: xbrl on 2026-06-30; 4 on 2026-04-02; 4 on 2026-04-02.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.